MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 21 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $381,000 | -76.4% | 300,000 | 0.0% | 0.00% | -75.0% |
| Q1 2016 | $1,614,000 | -29.6% | 300,000 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $2,292,000 | -8.4% | 300,000 | 0.0% | 0.01% | -16.7% |
| Q3 2015 | $2,502,000 | -28.1% | 300,000 | 0.0% | 0.01% | -14.3% |
| Q2 2015 | $3,480,000 | +29.0% | 300,000 | 0.0% | 0.01% | +40.0% |
| Q1 2015 | $2,697,000 | -14.7% | 300,000 | 0.0% | 0.01% | -16.7% |
| Q4 2014 | $3,162,000 | +62.9% | 300,000 | 0.0% | 0.01% | +50.0% |
| Q3 2014 | $1,941,000 | – | 300,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |